Designed Tripeptides as Potent NPM1 Oligomerization Inhibitors: A Molecular Docking and Dynamics Study Toward New Anticancer Drug Candidates. Int. J. Environ. Sci. [Internet]. 2026 Jan. 6 [cited 2026 Aug. 6];:537-4. Available from: https://theaspd.com/index.php/ijes/article/view/12707